TY  - JOUR

T1  - OR16-2 Osilodrostat Treatment in Cushing's Disease (CD): Results from a Phase III, Multicenter, Double-Blind, Randomized Withdrawal Study (LINC 3)

JO  - Journal of the Endocrine Society

PY  - 2019/04/15

AU  - Biller BMK

AU  - Newell-Price J

AU  - Fleseriu M

AU  - Bertagna X

AU  - Findling J

AU  - Shimatsu A

AU  - Lee EJ

AU  - Gu F

AU  - Auchus R

AU  - Leelawattana R

AU  - Lacroix A et al

ED  - 

DO  - DOI: 10.1210/js.2019-or16-2

PB  - The Endocrine Society

VL  - 3

IS  - Supplement_1

Y2  - 2024/12/22

ER  -